Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Classic TA Workplace -- Ignore unavailable to you. Want to Upgrade?

To: NOW who wrote (33615)	3/7/2002 3:41:20 PM
From: AllansAlias	Read Replies (1) \| Respond to of 209892

Don't think so. Still, eager bears would have seen a certain thing forming up here: bigcharts.marketwatch.com

To: NOW who wrote (33615)	3/7/2002 3:53:21 PM
From: bcrafty	Respond to of 209892

davidd, not really Actually, it looked kinda good since 2/25 or so. The stochastics were looking a bit overbought, but that's not much. And there was the RW in Allan's comment in the shorter picture. stockcharts.com[l,a]daclyyay[pc5!c8][vc60][iLh8,3!La12,26,9]&pref=G You can't expect TA to portend major events like a FDA disapproval any more than you could expect it to portend the bad conference call of GNSS last week. The chart might reflect news the street already "knows" when word is leaked, but if there's no leak, then there's not going to be much reflection of it in the charts. FDA approvals/disapprovals are one of the joys/dangers of being long on a biotech or drug stock.